ATAI Life Sciences NV (9VC) — Defensive Interval Ratio
ATAI Life Sciences NV (9VC) has a Defensive Interval Ratio of 1858 days as of September 2025. Defensive assets of €84.20 Million (cash €-, short-term investments €84.20 Million, receivables €-) cover 1858 days of daily cash needs of €45.33K/day. See ATAI Life Sciences NV working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
ATAI Life Sciences NV Defensive Interval Ratio (2021–2024)
This chart shows how ATAI Life Sciences NV's Defensive Interval Ratio has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the ratio stands at 1858 days, meaning defensive assets of €84.20 Million can fund 1858 days of operations without new revenue. See ATAI Life Sciences NV balance sheet quality to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for ATAI Life Sciences NV (2021–2024)
The table below presents the year-by-year Defensive Interval Ratio for ATAI Life Sciences NV from 2021 to 2024, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see ATAI Life Sciences NV stock valuation.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 656 days | €44.83 Million | €68.36K/day | €- | €44.83 Million | ▼ -1779 days |
| 2023 | 2435 days | €134.22 Million | €55.12K/day | €- | €134.22 Million | ▲ +922 days |
| 2022 | 1513 days | €82.50 Million | €54.51K/day | €- | €82.50 Million | ▲ +1513 days |
| 2021 | 0 days | €0.00 | €57.36K/day | €- | €0.00 | — |